Pharmacological Treatment of Patent Ductus Arteriosus in Preterm Infants
The patent ductus arteriosus contribute to many neonatal morbidities. There are different approaches for treatment including conservative, pharmacological and definitive closure. Most commonly, pharmacological therapy is attempted before consideration of surgical intervention.
Saved in:
| Main Author: | |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2022
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/81216 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Pharmacological Treatment of Patent Ductus Arteriosus in Preterm Infants
- Efficacy of pharmacological treatment for closure of patent ductus arteriosus in preterm newborns: a systematic review
- Recent Advances Concerning the Molecular Mechanism of Patent Ductus Arteriosus
- Relationship between Hypoxia and Pulmonary Microcirculation Hemorheology in Pediatric Patients with Patent Ductus Arteriosus Operated on at Moderate Altitude
- Persistent ductus arteriosus in an elderly dog
- Oxidative Stress and Antioxidants: Preterm Birth and Preterm Infants
- Brain Injury in Preterm Infants